Keyphrases
Childhood Cancer Survivors
100%
Survivors
56%
Childhood Cancer Survivor Study
35%
Breast Cancer Risk
27%
Polygenic Risk Score
27%
Genome-wide Association Study
24%
Long-term Survivors
21%
Single nucleotide Polymorphism
20%
Genetic Risk
20%
Rare Genotypes
18%
Black Hispanic
18%
COVID-19 Pandemic
18%
COVID-19 Mortality
18%
U.S. Counties
18%
Subsequent Malignant Neoplasms
17%
High Risk
16%
Hazard Ratio
14%
Chemotherapy
14%
Risk Prediction Model
14%
High-risk HPV
12%
Risk Effects
11%
Incidence Rate
10%
Breast Cancer
10%
Treatment-related
10%
Polygenic Risk
10%
Genome-wide Search
9%
Haplotype Association Analysis
9%
Zygosity
9%
Forgoing
9%
Genetic Architecture
9%
Bone Mineral Density
9%
Insurance Disparities
9%
Fracture Risk
9%
Rare Pattern
9%
Age-related Risk
9%
Primary Ovarian Insufficiency
9%
Novel Locus
9%
Lung
9%
Primary Biliary Cholangitis
9%
Major Adverse Cardiovascular Events
9%
Sex Therapy
9%
High-order Epistasis
9%
Treatment Effect
9%
Pattern Mining
9%
Clinical Population
9%
Racial-ethnic
9%
Subsequent Malignancies
9%
Late Mortality
9%
Gonadotoxic Treatment
9%
Medical Care
9%
Medicine and Dentistry
Childhood Cancer
72%
Lifespan
38%
Malignant Neoplasm
21%
Cohort Analysis
21%
Genome Wide Association Study
19%
Chemotherapy
15%
Single Nucleotide Polymorphism
13%
Radiation Therapy
10%
Hazard Ratio
9%
Emergency Department
9%
Flu Like Syndrome
9%
Medical Care
9%
Virus Detection
9%
COVID-19
9%
COVID-19 Mortality
9%
Clinical Population
9%
Cancer
9%
Primary Ovarian Insufficiency
9%
Cardiovascular System
9%
Sex Therapy
9%
Germ Cell
9%
Lung
9%
Cancer Diagnosis
7%
Coronary Artery Disease
5%
Proportional Hazards Model
5%
Biochemistry, Genetics and Molecular Biology
Haplotype
36%
Lifespan
33%
Genome-Wide Association Study
25%
Genetic Risk
22%
Germline
21%
Germ Cell
21%
Cohort Study
16%
Single-Nucleotide Polymorphism
15%
Polygenic Score
14%
Genome Wide Association Study
13%
Allele
12%
Genetics
11%
Early Menopause
9%
Bone Density
9%
Zygosity
9%
Genetic Architecture
9%
All Cause Mortality
9%
Single Nucleotide Polymorphism
8%
Gene Expression
6%
Population
6%
